30.12.2014 Views

2005 Annual report - Virbac

2005 Annual report - Virbac

2005 Annual report - Virbac

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

37<br />

Consolidated balance sheet and financing<br />

The Group’s cash flow from operations amounted to €39.9<br />

million compared to €29 million in 2004, representing an<br />

increase of 37.4% on the back of an improvement in the Group’s<br />

profitability. Net debt at 31 December <strong>2005</strong> fell sharply and now<br />

only represents €14.8 million (-60.9%). This improvement largely<br />

stems from the improvement in cash flow from operations,<br />

combined with tight controls on working capital requirements<br />

and low level of investment during <strong>2005</strong>. Net debt at end <strong>2005</strong><br />

only represented 0.4 times cash flow from operations and 8.2%<br />

of total shareholders’ equity and provisions (including minority<br />

interests).<br />

The increase in goodwill largely stems from the acquisition of the<br />

Greek distributor in July <strong>2005</strong>. The acquisition of intangible assets<br />

amounted to €3.7 million in <strong>2005</strong>, €2.6 million of which was<br />

for IS projects which were largely acquired or developed within<br />

the parent company (€2.5 million). Other acquisitions relate to<br />

licences, trademarks and similar rights.<br />

The Group’s tangible investments amounted to €5.9 million in<br />

<strong>2005</strong> and were largely for the improvement of the production<br />

units.<br />

The equity securities accounted for by the equity method relate to<br />

two small European companies in which <strong>Virbac</strong> SA has minority<br />

stakes.<br />

The working capital requirement rose by €9.3 million on the<br />

previous financial year. This change largely stems from the<br />

increase in trade receivables resulting from the high level of sales<br />

in the fourth quarter as well as by the rise in the exchange rate of<br />

certain currencies at the end of <strong>2005</strong> compared to the end of<br />

2004.<br />

On 23 December 2003, <strong>Virbac</strong> SA opened a credit line with a<br />

pool of banks for a period of 7 years and a maximum amount of<br />

€100 million.<br />

In this regard, the Group must fulfil two types of undertakings:<br />

◆ undertaking to respect financial ratios:<br />

- consolidated net debt/cash flow from operations;<br />

- consolidated net debt/shareholders’ equity;<br />

◆ undertaking to publish financial statements.<br />

This credit line was scarcely used at end <strong>2005</strong> and the Group fully<br />

complied with its contractual undertakings.<br />

Parent company financial statements<br />

The company first applied CRC regulation 2002-10 on<br />

amortisation and impairment and CRC regulation 2004-06<br />

on assets in the <strong>2005</strong> financial year.<br />

CRC regulation 2002-10 on amortisation and impairment:<br />

the translation method applied as from 1 January <strong>2005</strong> was<br />

the “reallocation of net carrying amounts” method, limited<br />

to assets with a net carrying amount in excess of<br />

€30 thousand at that date.<br />

The company proceeded as follows:<br />

◆ breakdown of constructions into components (buildings<br />

and fittings & fixtures),<br />

◆ breakdown of industrial equipment with a gross amount<br />

in excess of €150 thousand into components,<br />

◆ redefinition of amortisation schedules on the basis of<br />

useful lives.<br />

The amortisation resulting from the application of these<br />

useful lives being deemed to be economic amortisation.<br />

The company nevertheless continued to employ the use<br />

periods set out by the tax authorities and where possible<br />

applied the diminishing balance amortisation method.<br />

The differences resulting from the application of specific<br />

amortisation methods and periods are recognised in<br />

accelerated amortisation.<br />

CRC regulation 2004-06 on assets:<br />

Pursuant to CRC regulation 2004-06 deferred charges for a<br />

total of €168 thousand, relating to seed stock control<br />

expenses (general non-recurring expenditure with a<br />

beneficial impact over a number of years) were reclassified<br />

on 1 January <strong>2005</strong> as retained earnings.<br />

Expenses relating to internally produced brands were<br />

reversed in the balance sheet. As a result of a change in<br />

accounting regulations, this reversal (for the portion<br />

capitalised prior to <strong>2005</strong>) was recognised as retained<br />

earnings net of tax, namely €953 thousand.<br />

Moreover, in <strong>2005</strong>, the tax authorities audited the 2002 and<br />

2003 financial statements of <strong>Virbac</strong> SA. The company was<br />

notified of a restatement for the 2002 financial year. This<br />

audit gave rise to a provision of €544 thousand. The audit<br />

of the 2003 financial statements had not been completed as<br />

of the drawing up of the financial statements.<br />

Income trends<br />

At 31 December <strong>2005</strong>, sales in the <strong>Virbac</strong> SA parent<br />

company amounted to €133.5 million, up 12.3% on<br />

the previous year after having fallen for two straight years.<br />

The bulk of this growth is due to sales with Group<br />

companies that account for 89% of total sales (compared<br />

to 87% in 2004). Sales at Asian and Latin American<br />

subsidiaries declined slightly whereas sales in North<br />

American, Oceanian, South African and European<br />

subsidiaries rose sharply (these sales representing 91% of<br />

the sales of Group subsidiaries).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!